Motugivatrep

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameMotugivatrep
Drug Alias NameAvareptアバレプトSJP-0132EVT-10991998
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsDry Eye SyndromesXerophthalmia
Global Approved IndicationsXerophthalmia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2025/12/22
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSenju Pharmaceutical Science&Technology(Beijing) Co LtdSenju Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye SyndromesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG